Stocks making the biggest moves midday: Berkshire, AMD, Circle, FedEx, UPS & more

Midday trading was driven by a mix of company-specific catalysts: logistics stocks fell sharply after Amazon announced Amazon Supply Chain Services, with GXO down 11%, UPS down 10%, and FedEx and C.H. Robinson off 9%. On the upside, GlobalFoundries rose 4% after a Cantor upgrade and $80 target, Global Business Travel Group surged 57% on a $6.3 billion takeout by Long Lake, and Celcuity jumped nearly 18% after positive phase 3 breast cancer data. Crypto stocks rallied on bipartisan progress on the CLARITY Act, while Tyson gained about 3% on a Q2 earnings beat and AMD fell nearly 5% after a downgrade.

Analysis

The clearest second-order read is that Amazon is trying to monetize the lowest-margin, highest-friction layer of logistics rather than just selling more cloud or retail volume. That is structurally negative for incumbent freight forwarders and parcel intermediaries because the competitive pressure is not just on price; it is on control of routing, data, and customer relationship, which compresses take-rate over time. The market is likely pricing an early re-rating of “asset-light logistics” franchises, but the more durable implication is that Amazon can selectively attack lanes where incumbents still enjoy pricing power, forcing them into a slower margin-reset than a one-day selloff implies.

The earnings/guidance cluster in travel, biotech, and food is telling us the market is rewarding idiosyncratic execution and punishing macro sensitivity. NCLH’s cut underscores how quickly input shocks can overwhelm demand resilience, while Tyson’s beat suggests food names with better procurement discipline can still protect margin in a cost-up tape. In biotech, AXSM and CELC are being treated as binary clinical data stories, where the next catalyst is not revenue but either additional label expansion or financing optionality; that makes post-rally volatility high but also creates asymmetric upside if follow-on data validate the mechanism.

The crypto rally has a different setup: this is less about fundamental adoption overnight and more about regulatory de-risking compressing the discount rate on the entire ecosystem. The better read is that listed proxies with operating leverage to trading volumes and custody activity can move harder than Bitcoin itself over the next 1-3 months if legislative language keeps improving. Conversely, AMD looks vulnerable not because the business is weakening today, but because the market is already discounting a capacity-constrained 2026 that may not be tight enough to justify the current multiple if supply normalizes faster than expected.

Key Decisions for Investors

• Short a basket of freight/parcel exposure vs long AMZN on a 1-3 month horizon: short GXO/FDX/UPS, hedged with AMZN. Risk/reward favors a continued multiple reset in logistics if Amazon’s service ramps, with the long leg offsetting broad e-commerce strength.
• Buy NCLH on weakness only if fuel hedges are clarified; otherwise avoid until the next quarter. The stock can remain a value trap for 2-3 quarters if crude-linked costs stay elevated and management has to keep resetting estimates.
• Take a tactical long in COIN or HOOD versus short AMD for 4-8 weeks if the crypto bill keeps advancing. The thesis is that regulatory clarity lifts transaction activity faster than semiconductor supply constraints lift AMD's upside.
• Use AXSM and CELC as event-driven longs only with tight trailing stops; consider selling upside calls against the position after a 10-15% further move. The data are supportive, but biotech names at this stage can give back 20-30% quickly on financing or trial-noise headlines.
• Watch GBTG for post-deal spread behavior: long the stock only if arb mispricing widens meaningfully below offer value, otherwise avoid chasing. The best risk/reward is on a failed-close or regulatory delay rather than on the initial headline pop.